Lansforsakringar Fondforvaltning AB (publ)
Position in BSX — Boston Scientific Corp
CIK 2059323
Stockholm, V7
Position in BSX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$67,481,689
+$11,398,940 QoQ
Shares Held
1,581,108
+76.9% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#103
of 1,468 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $194,046,717 across 9 Medical Devices names. BSX ranks #1 (34.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
This page
|
1,581,108 | $67,481,689 | |
| 2 | ABT |
Abbott Laboratories
|
534,128 | $48,466,774 | |
| 3 | SYK |
Stryker Corp
|
81,022 | $25,508,966 | |
| 4 | MDT |
Medtronic plc
|
325,753 | $25,483,657 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
133,240 | $8,528,692 | |
| 6 | DXCM |
Dexcom Inc
|
91,840 | $6,185,424 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
62,564 | $5,386,134 | |
| 8 | STE |
STERIS plc
|
21,990 | $4,630,434 |
All Filings in BSX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,481,689 | 1,581,108 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $56,082,749 | 893,749 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $75,438,631 | 791,176 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $77,722,169 | 796,089 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $88,545,044 | 824,365 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $86,712,009 | 859,556 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $77,447,853 | 867,083 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||